HGEN logo

Humanigen (HGEN) EBIT

Annual EBIT

-$67.81 M
+$166.57 M+71.07%

December 31, 2022

Summary

Performance

1-Year Change

+71.07%

3-Year Change

-658.1%

5-Year Change

-258.21%

15-Year Change

-258.21%

HGEN EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$2.23 M

3-Year Low

-$234.38 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2022
HGEN previous annual earnings announcement was published on Dec 31, 2022

Next Annual Earnings Report Date

N/A
HGEN next annual earnings announcement has not yet been scheduled

OtherHGENprofitabilitymetrics:

Annual Revenue

$2.51 M
HGEN annual revenue is $2.51 million

Annual Net Income

-$70.73 M
HGEN annual net profit is -$70.73 million

Annual EBITDA

-$67.81 M
HGEN annual EBITDA is -$67.81 million

Annual EPS

-$0.79
HGEN annual earnings per share is -$0.79

Quarterly EBIT

-$4.16 M
-$8.67 M-192.37%

March 31, 2023

Summary

Performance

3-Month Change

-192.37%

1-Year Change

+79.73%

3-Year Change

-102.43%

5-Year Change

+11.27%

HGEN Quarterly EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$4.51 M
HGEN quarterly earnings before interest & taxes is currently -192.37% below its historical high of $4.51 million

3-Year Low

-$32.79 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HGEN previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HGEN next earnings announcement has not yet been scheduled

OtherHGENprofitabilitymetrics:

Quarterly Revenue

$221.00 K
HGEN quarterly revenue is $221.00 thousand

Quarterly Net Income

-$4.18 M
HGEN quarterly net profit is -$4.18 million

Quarterly EBITDA

-$4.16 M
HGEN quarterly EBITDA is -$4.16 million

Quarterly EPS

-$0.04
HGEN quarterly earnings per share is -$0.04

TTM EBIT

-$51.43 M
+$16.38 M+24.16%

March 31, 2023

Summary

Performance

3-Month Change

+24.16%

1-Year Change

+72.84%

3-Year Change

-486.92%

5-Year Change

-474.98%

HGEN TTM EBIT Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

-$479.00 K

3-Year Low

-$234.38 M

Earnings dates

Last Quarterly Earnings Report Date

Mar 31, 2023
HGEN previous earnings announcement was published on Mar 31, 2023

Next Quarterly Earnings Report Date

N/A
HGEN next earnings announcement has not yet been scheduled

OtherHGENprofitabilitymetrics:

TTM Revenue

$1.70 M
HGEN TTM revenue is $1.70 million

TTM Net Income

-$53.63 M
HGEN TTM net profit is -$53.63 million

TTM EBITDA

-$51.43 M
HGEN TTM EBITDA is -$51.43 million

TTM EPS

-$0.54
HGEN TTM earnings per share is -$0.54

EBIT Formula

EBIT = Revenue − COGS − Operating Expenses

Annual EBIT

-$67.81 M
HGEN annual earnings before interest & taxes is -$67.81 million

Annual Revenue

$2.51 M
HGEN annual revenue is $2.51 million

Annual Cost Of Goods Sold

-
HGEN annual cost of goods sold value is unknown

Annual Operating Expenses

$70.82 M
HGEN annual total operating expenses is $70.82 million

HGEN EBIT Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+71.1%+79.7%+72.8%
3 y3 years-658.1%-102.4%-486.9%
5 y5 years-258.2%+11.3%-475.0%

HGEN EBIT Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+245.6%-192.4%+687.5%at high+355.7%
5 y5-year+658.1%+245.6%-192.4%+1582.4%+486.9%+355.7%
alltimeall time+2938.2%+245.6%-192.4%+1582.4%>+9999.0%+355.7%

Humanigen EBIT History

DateAnnualQuarterlyTTM
Mar 2023
-
-$4.16 M(-192.4%)
-$51.43 M(-24.2%)
Dec 2022
-$67.81 M(-71.1%)
$4.51 M(-120.1%)
-$67.81 M(-35.5%)
Sep 2022
-
-$22.39 M(-23.8%)
-$105.11 M(-29.3%)
Jun 2022
-
-$29.38 M(+43.0%)
-$148.71 M(-21.5%)
Mar 2022
-
-$20.54 M(-37.4%)
-$189.38 M(-19.2%)
Dec 2021
-$234.38 M(+165.7%)
-$32.79 M(-50.3%)
-$234.38 M(+0.2%)
Sep 2021
-
-$65.99 M(-5.8%)
-$233.89 M(+17.7%)
Jun 2021
-
-$70.06 M(+6.9%)
-$198.65 M(+31.0%)
Mar 2021
-
-$65.55 M(+103.0%)
-$151.69 M(+72.0%)
Dec 2020
-$88.20 M(+886.0%)
-$32.30 M(+5.0%)
-$88.20 M(+53.2%)
Sep 2020
-
-$30.75 M(+33.1%)
-$57.58 M(+99.4%)
Jun 2020
-
-$23.10 M(+1022.9%)
-$28.88 M(+229.6%)
Mar 2020
-
-$2.06 M(+22.4%)
-$8.76 M(-2.0%)
Dec 2019
-$8.95 M(-19.8%)
-$1.68 M(-17.9%)
-$8.95 M(-0.9%)
Sep 2019
-
-$2.05 M(-31.3%)
-$9.03 M(-0.2%)
Jun 2019
-
-$2.98 M(+33.1%)
-$9.04 M(+4.0%)
Mar 2019
-
-$2.24 M(+27.0%)
-$8.70 M(-22.0%)
Dec 2018
-$11.15 M(-41.1%)
-$1.76 M(-14.4%)
-$11.15 M(-4.5%)
Sep 2018
-
-$2.06 M(-21.9%)
-$11.68 M(-24.8%)
Jun 2018
-
-$2.64 M(-43.8%)
-$15.53 M(-15.4%)
Mar 2018
-
-$4.69 M(+105.0%)
-$18.37 M(-3.0%)
Dec 2017
-$18.93 M(-29.6%)
-$2.29 M(-61.3%)
-$18.93 M(-12.5%)
Sep 2017
-
-$5.92 M(+8.2%)
-$21.64 M(+7.0%)
Jun 2017
-
-$5.47 M(+4.0%)
-$20.22 M(-24.3%)
Mar 2017
-
-$5.26 M(+5.1%)
-$26.72 M(-0.6%)
DateAnnualQuarterlyTTM
Dec 2016
-$26.89 M(-22.1%)
-$5.00 M(+11.4%)
-$26.89 M(-23.0%)
Sep 2016
-
-$4.49 M(-62.5%)
-$34.91 M(-5.1%)
Jun 2016
-
-$11.97 M(+120.5%)
-$36.80 M(+20.2%)
Mar 2016
-
-$5.43 M(-58.4%)
-$30.62 M(-11.3%)
Dec 2015
-$34.54 M(-6.1%)
-$13.03 M(+104.3%)
-$34.54 M(+11.8%)
Sep 2015
-
-$6.38 M(+10.2%)
-$30.90 M(-4.1%)
Jun 2015
-
-$5.79 M(-38.0%)
-$32.24 M(-10.4%)
Mar 2015
-
-$9.34 M(-0.6%)
-$35.98 M(-2.2%)
Dec 2014
-$36.78 M(-10.0%)
-$9.40 M(+21.8%)
-$36.78 M(-1.5%)
Sep 2014
-
-$7.71 M(-19.0%)
-$37.34 M(-8.2%)
Jun 2014
-
-$9.52 M(-6.1%)
-$40.68 M(-4.8%)
Mar 2014
-
-$10.15 M(+1.9%)
-$42.73 M(+4.5%)
Dec 2013
-$40.86 M(+75.2%)
-$9.96 M(-9.9%)
-$40.89 M(-4.3%)
Sep 2013
-
-$11.05 M(-4.5%)
-$42.71 M(+6.9%)
Jun 2013
-
-$11.57 M(+39.2%)
-$39.95 M(+31.0%)
Mar 2013
-
-$8.31 M(-29.4%)
-$30.49 M(+30.7%)
Dec 2012
-$23.32 M(+945.0%)
-$11.78 M(+42.0%)
-$23.33 M(+135.7%)
Sep 2012
-
-$8.29 M(+292.4%)
-$9.90 M(+288.5%)
Jun 2012
-
-$2.11 M(+84.2%)
-$2.55 M(+56.6%)
Mar 2012
-
-$1.15 M(-169.3%)
-$1.63 M(+239.5%)
Dec 2011
-$2.23 M(-63.5%)
$1.66 M(-275.7%)
-$479.00 K(-77.6%)
Sep 2011
-
-$942.00 K(-21.0%)
-$2.13 M(+79.0%)
Jun 2011
-
-$1.19 M
-$1.19 M
Dec 2010
-$6.12 M(-77.7%)
-
-
Dec 2009
-$27.46 M
-
-

FAQ

  • What is Humanigen annual earnings before interest & taxes?
  • What is the all time high annual EBIT for Humanigen?
  • What is Humanigen annual EBIT year-on-year change?
  • What is Humanigen quarterly earnings before interest & taxes?
  • What is the all time high quarterly EBIT for Humanigen?
  • What is Humanigen quarterly EBIT year-on-year change?
  • What is Humanigen TTM earnings before interest & taxes?
  • What is the all time high TTM EBIT for Humanigen?
  • What is Humanigen TTM EBIT year-on-year change?

What is Humanigen annual earnings before interest & taxes?

The current annual EBIT of HGEN is -$67.81 M

What is the all time high annual EBIT for Humanigen?

Humanigen all-time high annual earnings before interest & taxes is -$2.23 M

What is Humanigen annual EBIT year-on-year change?

Over the past year, HGEN annual earnings before interest & taxes has changed by +$166.57 M (+71.07%)

What is Humanigen quarterly earnings before interest & taxes?

The current quarterly EBIT of HGEN is -$4.16 M

What is the all time high quarterly EBIT for Humanigen?

Humanigen all-time high quarterly earnings before interest & taxes is $4.51 M

What is Humanigen quarterly EBIT year-on-year change?

Over the past year, HGEN quarterly earnings before interest & taxes has changed by +$16.38 M (+79.73%)

What is Humanigen TTM earnings before interest & taxes?

The current TTM EBIT of HGEN is -$51.43 M

What is the all time high TTM EBIT for Humanigen?

Humanigen all-time high TTM earnings before interest & taxes is -$479.00 K

What is Humanigen TTM EBIT year-on-year change?

Over the past year, HGEN TTM earnings before interest & taxes has changed by +$137.95 M (+72.84%)